Article Menu
Need Help?
No Article Versions Notes Found
Cite
Salman, A.; Simoneau, E.; Hassanain, M.; Chaudhury, P.; Boucher, L.M.; Valenti, D.; Cabrera, T.; Nudo, C.; Metrakos, P. Combined Sorafenib and Yttrium-90 Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma. Curr. Oncol. 2016, 23, 472-480. https://doi.org/10.3747/co.23.2827
Salman A, Simoneau E, Hassanain M, Chaudhury P, Boucher LM, Valenti D, Cabrera T, Nudo C, Metrakos P. Combined Sorafenib and Yttrium-90 Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma. Current Oncology. 2016; 23(5):472-480. https://doi.org/10.3747/co.23.2827
Chicago/Turabian StyleSalman, A., E. Simoneau, M. Hassanain, P. Chaudhury, L.M. Boucher, D. Valenti, T. Cabrera, C. Nudo, and P. Metrakos. 2016. "Combined Sorafenib and Yttrium-90 Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma" Current Oncology 23, no. 5: 472-480. https://doi.org/10.3747/co.23.2827
APA StyleSalman, A., Simoneau, E., Hassanain, M., Chaudhury, P., Boucher, L. M., Valenti, D., Cabrera, T., Nudo, C., & Metrakos, P. (2016). Combined Sorafenib and Yttrium-90 Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma. Current Oncology, 23(5), 472-480. https://doi.org/10.3747/co.23.2827
